| Literature DB >> 27257752 |
Yuan Guan1, Dan Xu1, Gary Peltz2.
Abstract
Two papers (Rezvani et al., 2016; Song et al., 2016) in this issue of Cell Stem Cell use transcription-factor-mediated reprogramming to convert liver myofibroblasts into hepatocyte-like cells in mice. Moreover, murine models of fibrotic and cholestatic liver injury were used to demonstrate that this approach has potential for treatment of liver cirrhosis.Entities:
Mesh：
Year: 2016 PMID： 27257752 DOI： 10.1016/j.stem.2016.05.007
Source DB: PubMed Journal: Cell Stem Cell ISSN： 1875-9777 Impact factor: 24.633